In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer-Reference-Cited by-同舟云学术

In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancer

Published:2018-08-29 Issue:1 Volume:9 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Zagorac Ivana,Fernandez-Gaitero Sara,Penning Renske,Post Harm,Bueno Maria J.,Mouron Silvana,Manso Luis^ORCID,Morente Manuel M.,Alonso Soledad,Serra Violeta^ORCID,Muñoz Javier,Gómez-López Gonzalo,Lopez-Acosta Jose Francisco,Jimenez-Renard Veronica,Gris-Oliver Albert,Al-Shahrour Fatima,Piñeiro-Yañez Elena,Montoya-Suarez Jose Luis,Apala Juan V.,Moreno-Torres Amalia,Colomer Ramon,Dopazo Ana,Heck Albert J. R.^ORCID,Altelaar Maarten,Quintela-Fandino Miguel

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-018-05742-z.pdf

Reference70 articles.

1. Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-negative breast cancer. N. Engl. J. Med. 363, 1938–1948 (2010).

2. Lehmann, B. D. et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J. Clin. Invest. 121, 2750–2767 (2011).

3. Curtis, C. et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 486, 346–352 (2012).

4. Shah, S. P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395–399 (2012).

5. Banerji, S. et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 486, 405–409 (2012).

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RUPE-phospho: Rapid Ultrasound-Assisted Peptide-Identification-Enhanced Phosphoproteomics Workflow for Microscale Samples;Analytical Chemistry;2023-11-27

2. Proteomics of Patient-derived Breast Tumours Identifies a Pro-migratory Osteomodulin-Cyclin Dependent Kinase 1 Axis which Drives Bone Metastasis;2023-11-05

3. Distribution of PD-L1, TROP2 and HER2- “lowness” in early triple-negative breast cancer: an opportunity for treatment de-escalation;Clinical and Translational Oncology;2023-10-18

4. Omics-Based Investigations of Breast Cancer;Molecules;2023-06-14

5. Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease;Communications Medicine;2023-05-10